LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW 85,200
-2,400 (-2.74%)
Sep 11, 2026, 3:30 PM KST
LigaChem Biosciences Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,139,503 | 6,323,571 | 3,975,267 | 1,827,289 | 1,092,804 | 1,352,308 | |
Market Cap Growth | -43.13% | 59.07% | 117.55% | 67.21% | -19.19% | 138.87% |
Enterprise Value | 2,799,045 | 5,787,020 | 3,458,030 | 1,723,146 | 929,358 | 1,262,535 |
Last Close Price | 85200.00 | 173700.00 | 109000.00 | 65000.00 | 42850.00 | 55800.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 509.64 | - | - | - |
Forward PE | - | 129.34 | 52.06 | 44.50 | 44.50 | 44.50 |
PS Ratio | 31.78 | 44.67 | 31.58 | 53.52 | 32.71 | 42.05 |
PB Ratio | 7.12 | 11.69 | 6.45 | 12.33 | 4.98 | 5.23 |
P/TBV Ratio | 10.64 | 15.69 | 6.54 | 12.94 | 5.19 | 5.44 |
P/FCF Ratio | - | - | 52.41 | - | - | - |
P/OCF Ratio | - | - | 50.66 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 28.34 | 40.88 | 27.47 | 50.47 | 27.82 | 39.26 |
EV/FCF Ratio | - | - | 45.59 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.09 | 0.06 | 0.05 |
Debt / FCF Ratio | - | - | 0.01 | - | - | - |
Net Debt / Equity Ratio | -0.86 | -0.87 | -0.80 | -0.59 | -0.72 | -0.65 |
Net Debt / EBITDA Ratio | 1.92 | 4.72 | 31.01 | 1.15 | 3.41 | 6.84 |
Net Debt / FCF Ratio | 1.96 | 3.70 | -6.50 | 1.37 | 13.96 | 2.79 |
Asset Turnover | 0.15 | 0.20 | 0.27 | 0.15 | 0.12 | - |
Inventory Turnover | 80.86 | 96.48 | 77.94 | 82.64 | 66.32 | - |
Quick Ratio | 8.78 | 8.20 | 4.46 | 3.21 | 6.61 | 13.35 |
Current Ratio | 9.37 | 8.54 | 4.70 | 3.63 | 6.70 | 13.45 |
Return on Equity (ROE) | -36.55% | -15.82% | 2.04% | -40.08% | -18.85% | - |
Return on Assets (ROA) | -19.81% | -9.24% | -2.82% | -22.86% | -11.54% | - |
Return on Invested Capital (ROIC) | -305.93% | -110.81% | -19.45% | -131.59% | -66.23% | -48.80% |
Return on Capital Employed (ROCE) | -37.50% | -16.60% | -3.40% | -53.00% | -22.50% | -10.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -5.69% | -1.18% | 0.20% | -4.03% | -4.13% | -1.73% |
FCF Yield | -6.20% | -2.02% | 1.91% | -3.48% | -1.03% | -4.46% |
Buyback Yield / Dilution | 0.08% | -4.68% | -22.36% | -1.38% | -16.13% | -0.47% |